At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Controlled-Release Misoprostol Vaginal Insert in Parous Women for Labor Induction: Randomized Trial
In Brief
A Phase 2 clinical trial evaluating Misoprostol vaginal insert 25 mcg, Misoprostol vaginal insert 50 mcg, and 2 other interventions for Labor Induction and Cervical Ripening. Completed, enrolled 124 participants across 6 sites.
Detailed Summary
The primary objective of the study was assessment of the efficacy of four dose reservoirs (25 mcg, 50 mcg, 100 mcg, 200 mcg) of intravaginal controlled release misoprostol administered for up to 24 hours. Efficacy was measured in terms of time from insert placement to vaginal delivery.
Study Details
Timeline
Interventions
One hydrogel polymer vaginal insert for up to 24h
One hydrogel polymer vaginal insert for up to 24h
One hydrogel polymer vaginal insert for up to 24h
One hydrogel polymer vaginal insert for up to 24h